Neufeld EF, Muenzer J. The mucopolysaccaridoses. In: Scriver C, Beaudet A, Sly W, Valle D, editors. The metabolic and molecular basis of inherited disease. New York: McGraw Hill; 2001. p. 3421–52.
Google Scholar
Galimberti C, Madeo A, Di Rocco M, Fiumara A. Mucopolysaccharidoses: early diagnostic signs in infants and children. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0550-5.
Rigoldi M, Verrecchia E, Manna R, Mascia MT. Clinical hints to diagnosis of attenuated forms of mucopolysaccharidosis. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0551-4.
Filocamo M, Tomanin R, Bertola F, Morrone A. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0553-2.
Hurler G. Ueber einen Typ multipler Abartungen, vorwiegetmd am Skelettsystem. Ztschr. f. Kinderheilk. 1920;XXIV:220.
Article
Google Scholar
Hunter C. A rare disease in two brothers. Proc R Soc Med. 1917;10:104–16.
CAS
PubMed
PubMed Central
Google Scholar
Morquio L. Sur une forme de dystrophie osseuse familiale. Arch de Med d Enfants. 1929;XXXII:129.
Google Scholar
Sanfilippo S, Podosin R, Langer LO, Good RA. Mental retardation associated with acid mucopolysacchariduria (heparitin sulfate type). J Pediatr. 1963;63:837–8.
Article
Google Scholar
Maroteaux P, Levêque B, Marie J, Lamy M. A new dysostosis with urinary elimination of chondroitin sulfate B. Presse Med. 1963;71:1849–52.
CAS
PubMed
Google Scholar
Manley G, Williams U. Urinary excretion of glycosaminoglycans in the various forms of gargoylism. J Clin Pathol. 1969;22:67–75.
Article
CAS
Google Scholar
Van Hoof F, Hers HG. Ultrastructure of the hepatic cells in Hurler's disease (gargoylism). C R Hebdomadaires Seances Acad Sci. 1964;259:1281–3.
CAS
Google Scholar
Fratantoni JC, Hall CW, Neufeld EF. The defect in Hurler’s and Hunter’s syndromes: faulty degradation of mucopolysaccharides. Proc Natl Acad Sci. 1968;60:699–706.
Article
CAS
Google Scholar
Fratantoni JC, Hall CW, Neufeld EF. The defect in hurler and hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation. Proc Natl Acad Sci. 1969;64:360–6.
Article
CAS
Google Scholar
Scheie HG, Hambrick GW Jr, Barness LA. A newly recognized forme fruste of Hurler's disease (gargoylism). Am J Ophthalmol. 1962;53:753–69.
Article
CAS
Google Scholar
McKusick VA, Kaplan D, Wise D, Hanley WB, Suddarth SB, Sevick ME, et al. The genetic mucopolysaccharidoses. Medicine. 1965;44:445–83.
Article
CAS
Google Scholar
Mueller OT, Shows TB, Opitz JM, Reynolds JF. Apparent allelism of the hurler, Scheie, and hurler/Scheie syndromes. Am J Med Genet. 1984;18:547–56.
Article
CAS
Google Scholar
Sly WS, Quinton BA, McAlister WH, Rimoin DL. Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis. J Pediatr. 1973;82:249–57.
Article
CAS
Google Scholar
Natowicz MR, Short MP, Wang Y Dickersin GR, Gebhardt MC, Rosenthal DI, et al. Clinical and biochemical manifestations of hyaluronidase deficiency. N Engl J Med. 1996;335(14):1029–33.
Article
CAS
Google Scholar
Coutinho MF, Matos L, Alves S. From bedside to cell biology: a century of history on lysosomal dysfunction. Gene. 2015;555:50–8.
Article
CAS
Google Scholar
de Duve C. From cytases to lysosomes. Fed Proc. 1964;23:1045–9.
CAS
Google Scholar
Laraway S, Breen C, Mercer J, Jones S, Wraith EJ. Does early use of enzyme replacement therapy alter the natural history of mucopolysaccharidosis I? Experience in three siblings. Mol Genet Metab. 2013;109:315–6.
Article
CAS
Google Scholar
Al-Sannaa Nouriya A, Bay L, Barbouth DS, Benhayoun Y, Goizet C, Guelbert N, et al. Early treatment with laronidase improves clinical outcomes in patients with attenuated MPS I: a retrospective case series analysis of nine sibships. Orphanet J Rare Dis. 2015;10:131.
Article
CAS
Google Scholar
Gabrielli O, Clarke LA, Ficcadenti A, Santoro L, Zampini L, Volpi N, et al. 12 year follow-up of enzyme-replacement therapy in two siblings with attenuated mucopolysaccharidosis I: the important role of early treatment. BMC Med Genet. 2016;17:19.
Article
Google Scholar
Aldenhoven M, Wynn RF, Orchard PJ, O’Meara A, Veys P, Fischer A, et al. Long-term outcome of hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015;125(13):2164–72.
Article
CAS
Google Scholar
Donati M, Pasquini E, Spada M, Polo G, Burlina A. Newborn screening in mucopolysaccharidoses. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0552-3.
Burton BK, Charrow J, Hoganson GE, Waggoner D, Tinkle B, Braddock SR, et al. Newborn screening for lysosomal storage disorders in Illinois: the initial 15-month experience. J Pediatr. 2017;190:130–5.
Article
Google Scholar
Parini R, Corbetta C. Metabolic screening for the newborn. J Matern Fetal Neonatal Med. 2011;24(Suppl 2):6–8.
Article
Google Scholar
Grabowski GA, Whitley C. Ten plus one challenges in diseases of the lysosomal system. Mol Genet Metab. 2017;120:38–46.
Article
CAS
Google Scholar
Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K, et al. Reversal of clinical features of Hurler’s disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet. 1981;2(8249):709–12.
Article
CAS
Google Scholar
Boelens JJ, van Hasselt PM. Neurodevelopmental outcome after hematopoietic cell transplantation in inborn errors of metabolism: current considerations and future perspectives. Neuropediatrics. 2016;47(5):285–92.
Article
Google Scholar
de Ru MH, Boelens JJ, Das AM, Jones SA, van der Lee JH, Mahlaoui N, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis. 2011;6:55.
Article
Google Scholar
van der Linden MH, Kruyt MC, Sakkers RJ, de Koning TJ, Oner FC, Castelein RM. Orthopaedic management of Hurler’s disease after hematopoietic stem cell transplantation: a systematic review. J Inherit Metab Dis. 2011;34:657–69.
Article
Google Scholar
Coppa GV, Gabrielli O, Zampini L, Pierani P, Giorgi PL, Jezequel AM, et al. Bone marrow transplantation in hunter syndrome. J Inherit Metab Dis. 1995;18:91–2.
Article
CAS
Google Scholar
McKinnis EJ, Sulzbacher S, Rutledge JC, Sanders J, Scott CR. Bone marrow transplantation in hunter syndrome. J Pediatr. 1996;129:145–8.
Article
CAS
Google Scholar
Guffon N, Bertrand Y, Forest I, Fouilhoux A, Froissart R. Bone marrow transplantation in children with hunter syndrome: outcome after 7 to 17 years. J Pediatr. 2009;154:733–7.
Article
Google Scholar
Klein K, Krivit W, Whitley C, et al. Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment. Bone Marrow Trans. 1995;15(Suppl):S176–81.
Google Scholar
Sivakumur P, Wraith JE. Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling. J Inherit Metab Dis. 1999;22:849–50.
Article
CAS
Google Scholar
Welling L, Marchal JP, van Hasselt P, van der Ploeg AT, Wijburg FA, Boelens JJ. Early umbilical cord blood-derived stem cell transplantation does not prevent neurological deterioration in mucopolysaccharidosis type III. JIMD Reports. 2015;18:63–8.
Article
Google Scholar
Barth AL, de Magalhães T, Reis ABR, de Oliveira ML, Scalco FB, Cavalcanti NC, et al. Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: a 7 years follow-up. Mol Genet Metab Reports. 2017;12:62–8.
Article
Google Scholar
Kubaski F, Yabe H, Suzuki Y, Seto T, Hamazaki T, Mason RW, et al. Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II. Biol Blood Marrow Transplant. 2017;23(10):1795–803.
Article
CAS
Google Scholar
Tanaka A, Okuyama T, Suzuki Y, Sakai N, Takakura H, Sawada T, et al. Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan. Mol Genet Metab. 2012;107:513–20.
Article
CAS
Google Scholar
Tomatsu S, Sawamoto K, Alméciga-Díaz CJ, Shimada T, Bober MB, Chinen Y. Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio a syndrome. Drug Design Develop Ther. 2015;9:1937–53.
Article
CAS
Google Scholar
Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, et al. Hematopoietic stem cell transplantation for Morquio a syndrome. Mol Genet Metab. 2016;117(2):84–94.
Article
CAS
Google Scholar
Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA. Mol Genet Metab Rep. 2014;1:31–41.
Article
Google Scholar
Turbeville S, Nicely H, Rizzo JD, Pedersen TL, Orchard PJ, Horwitz ME, et al. Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI. Mol Genet Metab. 2011;102:111–5.
Article
CAS
Google Scholar
Jester S, Larsson J, Eklund EA, Papadopoulou D, Månsson JE, Békássy AN, et al. Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome. Orphanet J Rare Dis. 2013;8:134.
Article
Google Scholar
Mitchell R, Nivison-Smith I, Anazodo A, Tiedemann K, Shaw PJ, Teague L, et al. Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand children’s haematology oncology group and the Australasian bone marrow transplant recipient registry. Pediatr Transplant. 2013;17:582–8.
Article
CAS
Google Scholar
Sillence D, Waters K, Donaldson S, Shaw PJ, Ellaway C. Combined enzyme replacement therapy and hematopoietic stem cell transplantation in mucopolysaccharidosis type VI. JIMD Rep. 2012;2:103–6.
Article
CAS
Google Scholar
Concolino D, Deodato F, Parini R. Enzyme replacement therapy: efficacy and limitations. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0562-1.
Fecarotta S, Gasperini S, Parenti G. New treatments for the mucopolysaccharidoses: from pathophysiology to therapy. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0564-z.
Bellettato C, Scarpa M. Possible strategies to cross the blood–brain barrier. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0563-0.
Fraldi A, Serafini M, Sorrentino NC, Gentner B, Aiuti A, Bernardo ME. Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0565-y.
Moretto A, Bosatra M, Marchesini L, Tesoro S. Anesthesiological risks in mucopolysaccharidoses. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0554-1.
Bianchi P, Gaini R, Vitale S. ENT and mucopolysaccharidoses. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0555-0.
Borgo A, Cossio A, Gallone D, Vittoria F, Carbone M. Orthopaedic challenges for mucopolysaccharidoses. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0557-y.
Giussani C, Guida L, Canonico F, Sganzerla E. Cerebral and occipito-atlanto-axial involvement in mucopolysaccharidosis patients: clinical, radiological, and neurosurgical features. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0558-x.
Del Longo A, Piozzi E, Schweizer F. Ocular features in mucopolysaccharidosis: diagnosis and treatment. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0559-9.
Boffi L, Russo P, Limongelli G. Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0560-3.
Spina V, Barbuti D, Gaeta A, Palmucci S, Soscia E, Grimaldi M, et al. The role of imaging in the skeletal involvement of mucopolysaccharidoses. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0556-z.
Barone R, Pellico A, Pittalà A, Gasperini S. Neurobehavioral phenotypes of neuronopathic mucopolysaccharidoses. Ital J Pediatr. 2018. https://doi.org/10.1186/s13052-018-0561-2.
Ribeiro EM, Fonteles CS, Freitas AB, da Silva Alves KS, Monteiro AJ, da Silva CA. A clinical multicenter study of orofacial features in 26 Brazilian patients with different types of mucopolysaccharidosis. Cleft Palate Craniofac J. 2015;52(3):352–8.
Article
Google Scholar
Kantaputra PN, Kayserili H, Güven Y, Kantaputra W, Balci MC, Tanpaiboon P, et al. Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI. J Inherit Metab Dis. 2014;37(2):263–8.
Article
Google Scholar
Kampmann C, Wiethoff CM, Huth RG, Staatz G, Mengel E, Beck M. Management of life-threatening tracheal stenosis and tracheomalacia in patients with mucopolysaccharidoses. JIMD Rep. 2017;33:33–9.
Article
Google Scholar
Tomatsu S, Averill LW, Sawamoto K, Mackenzie WG, Bober MB, Pizarro C, et al. Obstructive airway in Morquio a syndrome, the past, the present and the future. Mol Genet Metab. 2016;117:150–6.
Article
CAS
Google Scholar
Pizarro C, Davies RR, Theroux M, Spurrier EA, Averill LW, Tomatsu S. Surgical reconstruction for severe tracheal obstruction in Morquio a syndrome. Ann Thorac Surg. 2016;102:e329–31.
Article
Google Scholar
Couce ML, del Toro M, García-Jiménez MC, Gutierrez-Solana L, Hermida-Ameijeiras Á, López-Rodríguez M, et al. Transition from pediatric care to adult care for patients with mucopolysaccharidosis. Rev Clin Esp. 2018;218(1):17–21.
Article
CAS
Google Scholar